Antenatal Detection of Fetal Growth Restriction and Stillbirths Rate.
REPERE
1 other identifier
observational
480
1 country
21
Brief Summary
The main objective is to assess the role of antenatal detection of fetal growth restriction (FGR) on stillbirth, by a case-control study in a population-based sample of small for gestational age (SGA) livebirths and stillbirths in 3 French counties (Isère, Savoie and Haute-Savoie). SGA births will be defined as a birthweight below the 10th percentile of French customised birth weight curves. Our secondary objectives are
- to identify determinants of antenatal detection of FGR among a representative sample of SGA births, with a special interest in the definition of FGR. Our hypothesis is that births who are SGA by customised birthweight curves and non-SGA by population birthweight curves, are not detected antenatally, despite the current strategy including the use of umbilical Doppler.
- to analyse prenatal care of a subsample of SGA stillbirths with and without detection of FGR by a confidential enquiry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2013
Typical duration for all trials
21 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 8, 2013
CompletedFirst Posted
Study publicly available on registry
November 27, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedAugust 4, 2015
December 1, 2014
1.7 years
November 8, 2013
July 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of antenatal detection of FGR
Crude and adjusted OR of stillbirth according to antenatal detection of FGR
baseline
Secondary Outcomes (2)
Factors associated with lack of antenatal detection of FGR in a representative sample of SGA births
baseline
fetal deaths of SGA newborns with and without antenatal detection of FGR
baseline
Study Arms (2)
SGA stillbirths (Cases)
Stillbirths, SGA births (below the 10th percentile of French customised birthweight curves), born in 2012-13, at or after 24 completed weeks of gestational age, without lethal congenital anomalies, to mothers residents in Isère, Savoie or Haute-Savoie
SGA livebirths (Controls)
Livebirths, SGA births (below the 10th percentile of French customised birthweight curves), born in 2013, at or after 24 completed weeks of gestational age, without lethal congenital anomalies, to mothers residents in Isère, Savoie or Haute-Savoie
Interventions
FGR is considered as "identified" if: * FGR was mentioned in medical charts * OR at least one ultrasound fetometry had indicated an estimated fetal weight or an abdominal diameter below the 10th percentile (whatever the reference curve used) * OR no (or insufficient) weight gain between two ultrasounds mentioned in medical charts * OR pathological Doppler examination of the umbilical artery (absent or reversed blood flow at the end of diastole) * OR utero-placental Doppler ultrasound indicated for suspicion of growth failure
Eligibility Criteria
SGA births to mothers residents in 3 French districts (Isère, Savoie and Haute-Savoie)
You may qualify if:
- Births:
- Stillbirths (antepartum or intrapartum fetal death) (=Cases) or livebirths (=Controls)
- at or after 24 completed weeks of gestational age
- singletons
- to mothers residents in 1 of the 3 districts (Isère, Savoie, Haute-Savoie) of the RHEOP register
- SGA: birthweight below the 10th percentile of French customised birthweight curves)
You may not qualify if:
- Fetal deaths with date of death estimated being older than date of birth by at least 1 week
- Lethal congenital anomalies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (21)
CH Albertville-Moutiers
Albertville, 73200, France
Clinique Générale Annecy
Annecy, 74000, France
CH Annecy
Annecy, 74374, France
Polyclinique de Savoie Annemasse
Annemasse, 74100, France
CHI Annemasse Bonneville
Bonneville, 74107, France
CH Bourg Saint Maurice
Bourg-Saint-Maurice, 73704, France
Centre Hospitalier Bourgoin Jallieu
Bourgoin, 38300, France
Clinique Saint Vincent de Paul Bourgoin Jallieu
Bourgoin, 38300, France
Hopital Femme Mere Enfant
Bron, 69677, France
CH Chambéry
Chambéry, 73000, France
Clinique des Cèdres
Échirolles, 38432, France
Chu Grenoble
Grenoble, 38000, France
Clinique Mutualiste Eaux Claires
Grenoble, 38000, France
Hopital Croix rousse
Lyon, 69317, France
Clinique Belledonne
Saint Martin D Hères, 38400, France
CH Saint Jean de Maurienne
Saint-Jean-de-Maurienne, 73303, France
CH Sud Léman Valserine
Saint-Julien-en-Genevois, 74164, France
Hôpitaux du Mont Blanc
Sallanches, 74700, France
Hôpitaux du Léman
Thonon-les-Bains, 74203, France
Centre Hospitalier Vienne
Vienne, 38209, France
Centre Hospitalier Voiron
Voiron, 38506, France
Related Publications (20)
Altman DG, Hytten FE. Intrauterine growth retardation: let's be clear about it. Br J Obstet Gynaecol. 1989 Oct;96(10):1127-32. doi: 10.1111/j.1471-0528.1989.tb03185.x. No abstract available.
PMID: 2590650BACKGROUNDPardi G, Marconi AM, Cetin I. Placental-fetal interrelationship in IUGR fetuses--a review. Placenta. 2002 Apr;23 Suppl A:S136-41. doi: 10.1053/plac.2002.0802.
PMID: 11978072BACKGROUNDKaufmann P SI. Placental development. In: Polin RA FW, eds, editor. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1998:59-70.
BACKGROUNDBaschat AA. Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance. Obstet Gynecol Surv. 2004 Aug;59(8):617-27. doi: 10.1097/01.ogx.0000133943.54530.76.
PMID: 15277896BACKGROUNDHecher K, Snijders R, Campbell S, Nicolaides K. Fetal venous, intracardiac, and arterial blood flow measurements in intrauterine growth retardation: relationship with fetal blood gases. Am J Obstet Gynecol. 1995 Jul;173(1):10-5. doi: 10.1016/0002-9378(95)90161-2.
PMID: 7631665BACKGROUNDSeveri FM, Bocchi C, Visentin A, Falco P, Cobellis L, Florio P, Zagonari S, Pilu G. Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol. 2002 Mar;19(3):225-8. doi: 10.1046/j.1469-0705.2002.00652.x.
PMID: 11896941BACKGROUNDHaws RA, Yakoob MY, Soomro T, Menezes EV, Darmstadt GL, Bhutta ZA. Reducing stillbirths: screening and monitoring during pregnancy and labour. BMC Pregnancy Childbirth. 2009 May 7;9 Suppl 1(Suppl 1):S5. doi: 10.1186/1471-2393-9-S1-S5.
PMID: 19426468BACKGROUNDImdad A, Yakoob MY, Siddiqui S, Bhutta ZA. Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduction of IUGR related stillbirths. BMC Public Health. 2011 Apr 13;11 Suppl 3(Suppl 3):S1. doi: 10.1186/1471-2458-11-S3-S1.
PMID: 21501426BACKGROUNDAlfirevic Z, Neilson JP. Doppler ultrasonography in high-risk pregnancies: systematic review with meta-analysis. Am J Obstet Gynecol. 1995 May;172(5):1379-87. doi: 10.1016/0002-9378(95)90466-2.
PMID: 7755042BACKGROUNDBricker L, Neilson JP. Routine ultrasound in late pregnancy (after 24 weeks gestation). Cochrane Database Syst Rev. 2000;(2):CD001451. doi: 10.1002/14651858.CD001451.
PMID: 10796263BACKGROUNDBricker L, Neilson JP, Dowswell T. Routine ultrasound in late pregnancy (after 24 weeks' gestation). Cochrane Database Syst Rev. 2008 Oct 8;(4):CD001451. doi: 10.1002/14651858.CD001451.pub3.
PMID: 18843617BACKGROUNDNeilson JP AZ. Doppler ultrasound for fetal assessment in high risk pregnancies (Cochrane review). The Cochrane Library, Issue 1, Oxford:Update software, 2002.
BACKGROUNDGRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG. 2003 Jan;110(1):27-32. doi: 10.1046/j.1471-0528.2003.02014.x.
PMID: 12504932BACKGROUNDThornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M; GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet. 2004 Aug 7-13;364(9433):513-20. doi: 10.1016/S0140-6736(04)16809-8.
PMID: 15302194BACKGROUNDBais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP. Effectiveness of detection of intrauterine growth retardation by abdominal palpation as screening test in a low risk population: an observational study. Eur J Obstet Gynecol Reprod Biol. 2004 Oct 15;116(2):164-9. doi: 10.1016/j.ejogrb.2004.01.037.
PMID: 15358457BACKGROUNDJahn A, Razum O, Berle P. Routine screening for intrauterine growth retardation in Germany: low sensitivity and questionable benefit for diagnosed cases. Acta Obstet Gynecol Scand. 1998 Jul;77(6):643-8. doi: 10.1034/j.1600-0412.1998.770611.x.
PMID: 9688242BACKGROUNDMattioli KP, Sanderson M, Chauhan SP. Inadequate identification of small-for-gestational-age fetuses at an urban teaching hospital. Int J Gynaecol Obstet. 2010 May;109(2):140-3. doi: 10.1016/j.ijgo.2009.11.023. Epub 2010 Feb 2.
PMID: 20129608BACKGROUNDLindqvist PG, Molin J. Does antenatal identification of small-for-gestational age fetuses significantly improve their outcome? Ultrasound Obstet Gynecol. 2005 Mar;25(3):258-64. doi: 10.1002/uog.1806.
PMID: 15717289BACKGROUNDOgundipe EM, Wolfe CD, Seed P, Gamsu HR. Does the antenatal detection of small-for-gestational-age babies influence their two-year outcomes? Am J Perinatol. 2000;17(2):73-81. doi: 10.1055/s-2000-9273.
PMID: 11023165BACKGROUNDFretts RC, Boyd ME, Usher RH, Usher HA. The changing pattern of fetal death, 1961-1988. Obstet Gynecol. 1992 Jan;79(1):35-9.
PMID: 1727582BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Ego, MD PhD
University Hospital, Grenoble
- STUDY CHAIR
Christine CANS, MD PHD
Registre Handicaps de l'Enfant et Observatoire Périnatal
- STUDY DIRECTOR
Jennifer Zeitlin, MD PHD
INSERM U953
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Week
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2013
First Posted
November 27, 2013
Study Start
November 1, 2013
Primary Completion
July 1, 2015
Study Completion
December 1, 2015
Last Updated
August 4, 2015
Record last verified: 2014-12